SCHEMBL6747686

SCHEMBL6747686

c1ccc(-c2ccc(-c3sc(-c4cccc(-c5ccccn5)n4)c4c3OCCO4)cn2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
LMNA P02545 3/20 0.45
CCR1 P32246 3/20 0.45
CCR5 P51681 3/20 0.45
CCR8 P51685 3/20 0.45
TP53 P04637 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALOX15 P16050 2/20 0.45
HTT P42858 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ALPL P05186 1/20 0.45
HSP90AA1 P07900 1/20 0.45
ALPI P09923 1/20 0.45
ALPG P10696 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HPGDS O60760 2/20 0.38
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
P4HTM Q9NXG6 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6747668 0.92 HPGDS (0.43) KDM4ELMNACCR1CCR5CCR8
SCHEMBL6744259 0.89 KDM4E (0.56) KDM4ELMNACCR1CCR5CCR8
SCHEMBL6744671 0.79 KDM4E (0.46) KDM4ELMNACCR1CCR5CCR8
SCHEMBL6745937 0.78 KDM4E (0.49) KDM4ELMNACCR1CCR5CCR8
SCHEMBL20885132 0.76 KDM4E (0.72) KDM4ELMNACCR1CCR5CCR8
SCHEMBL6744236 0.75 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL9971712 0.72 CD274 (0.31) SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL6747698 0.72 HPGDS (0.43) KDM4ELMNACCR1CCR5CCR8
SCHEMBL6747696 0.71 KDM4E (0.69) KDM4ELMNACCR1CCR5CCR8
SCHEMBL6743821 0.71 HPGDS (0.52) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696182-B2 HIGH PERFORMANCE DIPYRIDYL THIOPHENE OR DIPYRIDYL THIOPHENE DIOXIDE ELECTRON TRANSPORT MATERIALS WHICH WHEN EMPLOYED CAN GIVE LOW-VOLTAGE, HIGH EFFICIENCY ORGANIC ELECTROLUMINESCENT DEVICES CHISSO CORPORATION (JP) 2004-02-24 US disclosed
EP-1186605-B1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORP (JP) 2003-04-16 EP disclosed
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-21 US disclosed
EP-1186605-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative LAGE3, MAL2, ELF3 KDM4E 276/4885LMNA 2640/4885CCR1 545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.